{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T16:03:24Z","timestamp":1784477004465,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Orthop Trauma Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) is used in shoulder arthroplasty to reduce blood loss. While intravenous (IV) TXA is standard, oral TXA offers advantages in cost and administration. This study compares 90-day complications and postoperative laboratory values between IV and oral TXA in total shoulder arthroplasty (TSA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study using TriNetX identified adults undergoing primary TSA (2005\u20132025) receiving TXA on the day of surgery, stratified by route (IV vs. oral). One-to-one propensity score matching was performed. Ninety-day outcomes included transfusion, thromboembolic events, cardiac and renal complications, neurologic events, infection, wound dehiscence, readmissions, emergency department visits, opioid utilization, and mortality. Postoperative laboratory outcomes included hemoglobin, erythrocyte count, hematocrit, and platelet count. Outcomes were compared using odds ratios (ORs) with 95% confidence intervals (CIs) and t tests where appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After matching, 5722 patients were included in each cohort. No significant differences were observed between IV and oral TXA in 90-day transfusion rates (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.873) or thromboembolic events, including deep vein thrombosis and pulmonary embolism. Rates of myocardial infarction, stroke, cardiac ischemia, acute renal failure, infection, readmission, emergency department visits, opioid use, and mortality were also comparable between groups (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05). Postoperative laboratory values, including hemoglobin, erythrocyte count, hematocrit, and platelet count, did not differ significantly between IV and oral TXA cohorts (all\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.14).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this large propensity-matched analysis, oral TXA demonstrated equivalent safety, complication rates, and postoperative laboratory profiles compared with IV TXA following TSA. These findings support oral TXA as a clinically effective alternative to IV administration, offering potential advantages in cost reduction and resource utilization without compromising patient safety. Future prospective studies should evaluate optimal dosing strategies, patient-specific selection criteria, and formal cost-effectiveness analyses to further define the role of oral TXA in shoulder arthroplasty pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of evidence<\/jats:title>\n                    <jats:p>III, Retrospective Cohort Study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00402-026-06426-w","type":"journal-article","created":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T15:49:55Z","timestamp":1784476195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous versus oral tranexamic acid in shoulder arthroplasty"],"prefix":"10.1007","volume":"146","author":[{"given":"Tarishi","family":"Parmar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akin","family":"Adio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Daher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"issue":"1","key":"6426_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xrrt.2025.100614","volume":"6","author":"BJ Ambrose Martino","year":"2026","unstructured":"Ambrose Martino BJ, Northrop M, Rogalski BL, Eichinger JK, Friedman RJ (2026) Tranexamic acid in shoulder surgery: a comprehensive review of efficacy, safety, and clinical use. JSES Rev Rep Tech 6(1):100614. https:\/\/doi.org\/10.1016\/j.xrrt.2025.100614","journal-title":"JSES Rev Rep Tech"},{"issue":"Suppl 6","key":"6426_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2024.111846","volume":"55","author":"A Benjumea-Carrasco","year":"2024","unstructured":"Benjumea-Carrasco A, Guembe M, D\u00edaz-Navarro M, Mu\u00f1oz P, Vaquero-Martin J, Chana-Rodriguez F (2024) The role of tranexamic acid for infection prevention after fracture fixation. Injury 55(Suppl 6):111846. https:\/\/doi.org\/10.1016\/j.injury.2024.111846","journal-title":"Injury"},{"issue":"4","key":"6426_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jses.2019.08.003","volume":"3","author":"KA Burns","year":"2019","unstructured":"Burns KA, Robbins LM, LeMarr AR, Childress AL, Morton DJ, Wilson ML (2019) Estimated blood loss and anemia predict transfusion after total shoulder arthroplasty: a retrospective cohort study. JSES Open Access 3(4):311\u2013315. https:\/\/doi.org\/10.1016\/j.jses.2019.08.003","journal-title":"JSES Open Access"},{"issue":"2","key":"6426_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jseint.2024.10.013","volume":"9","author":"AJ Cecora","year":"2025","unstructured":"Cecora AJ, Ragland D, Vallurupalli N, Ben-Ari E, Xu JJ, Molokwu BO et al (2025) Projections of utilization of primary and revision shoulder arthroplasty in the United States in the next 40 years. JSES Int 9(2):472\u2013476. https:\/\/doi.org\/10.1016\/j.jseint.2024.10.013","journal-title":"JSES Int"},{"issue":"2","key":"6426_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11420-013-9327-y","volume":"9","author":"AF Chen","year":"2013","unstructured":"Chen AF, Klatt BA, Yazer MH, Waters JH (2013) Blood utilization after primary total joint arthroplasty in a large hospital network. HSS J 9(2):123\u2013128. https:\/\/doi.org\/10.1007\/s11420-013-9327-y","journal-title":"HSS J"},{"issue":"10","key":"6426_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/BRS.0000000000005250","volume":"50","author":"M Daher","year":"2025","unstructured":"Daher M, Xu A, Singh M, Lafage R, Line BG, Lenke LG et al (2025) Redefining clinically significant blood loss in complex adult spine deformity surgery. Spine 50(10):645\u2013651. https:\/\/doi.org\/10.1097\/BRS.0000000000005250","journal-title":"Spine"},{"issue":"2","key":"6426_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bja.2022.11.003","volume":"130","author":"CJ DeFrancesco","year":"2023","unstructured":"DeFrancesco CJ, Reichel JF, Gbaje E, Popovic M, Freeman C, Wong M et al (2023) Effectiveness of oral versus intravenous tranexamic acid in primary total hip and knee arthroplasty: a randomised, non-inferiority trial. Br J Anaesth 130(2):234\u2013241. https:\/\/doi.org\/10.1016\/j.bja.2022.11.003","journal-title":"Br J Anaesth"},{"key":"6426_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-025-09193-8","volume":"26","author":"P Feng","year":"2025","unstructured":"Feng P, Feng L, Xiong Z, Zhang C, Wang G (2025) A comparison of efficacy and safety of oral versus intravenous applications of tranexamic acid in total hip and knee arthroplasty: an updated systematic review meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 26:914. https:\/\/doi.org\/10.1186\/s12891-025-09193-8","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"6426_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.sart.2021.12.006","volume":"32","author":"R Gao","year":"2022","unstructured":"Gao R, Hirner M, van Niekerk M, Ledesma E, Gibson A, Campbell A et al (2022) Oral and intravenous tranexamic acid are equivalent at reducing blood loss following shoulder arthroplasty\u2014a multicenter, double-blinded, randomized, placebo-controlled trial. Semin Arthroplast JSES 32(2):415\u2013420. https:\/\/doi.org\/10.1053\/j.sart.2021.12.006","journal-title":"Semin Arthroplast JSES"},{"key":"6426_CR10","doi-asserted-by":"publisher","unstructured":"Gruson KI, Lo Y, Stallone S, Qawasmi F, Lee S, Shah P (2022) A comparison of operative time and intraoperative blood volume loss between stemless and short-stem anatomic total shoulder arthroplasty: a single institution\u2019s experience. JAAOS Glob Res Rev 6(7). https:\/\/doi.org\/10.5435\/JAAOSGlobal-D-22-00141","DOI":"10.5435\/JAAOSGlobal-D-22-00141"},{"issue":"5","key":"6426_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2106\/JBJS.16.00188","volume":"99","author":"E Kayupov","year":"2017","unstructured":"Kayupov E, Fillingham YA, Okroj K, Plummer DR, Moric M, Gerlinger TL et al (2017) Oral and intravenous tranexamic acid are equivalent at reducing blood loss following total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 99(5):373\u2013378. https:\/\/doi.org\/10.2106\/JBJS.16.00188","journal-title":"J Bone Joint Surg Am"},{"key":"6426_CR12","unstructured":"Khan AI, Goldin J, Gupta G (2025) Noninfectious complications of blood transfusion [Internet]. In: StatPearls. StatPearls Publishing, Treasure Island. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK574536\/. Accessed 14 Jan 2026"},{"issue":"7","key":"6426_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/rapm-2020-101301","volume":"45","author":"MA Kirksey","year":"2020","unstructured":"Kirksey MA, Wilson LA, Fiasconaro M, Poeran J, Liu J, Memtsoudis SG (2020) Tranexamic acid administration during total joint arthroplasty surgery is not associated with an increased risk of perioperative seizures: a national database analysis. Reg Anesth Pain Med 45(7):505\u2013508. https:\/\/doi.org\/10.1136\/rapm-2020-101301","journal-title":"Reg Anesth Pain Med"},{"issue":"21","key":"6426_CR14","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.3390\/jcm10215123","volume":"10","author":"A Klug","year":"2021","unstructured":"Klug A, Herrmann E, Fischer S, Hoffmann R, Gramlich Y (2021) Projections of primary and revision shoulder arthroplasty until 2040: facing a massive rise in fracture-related procedures. J Clin Med 10(21):5123. https:\/\/doi.org\/10.3390\/jcm10215123","journal-title":"J Clin Med"},{"issue":"1","key":"6426_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.24558","volume":"79","author":"I Lecker","year":"2016","unstructured":"Lecker I, Wang D, Whissell PD, Avramescu S, Mazer CD, Orser BA (2016) Tranexamic acid\u2013associated seizures: causes and treatment. Ann Neurol 79(1):18\u201326. https:\/\/doi.org\/10.1002\/ana.24558","journal-title":"Ann Neurol"},{"issue":"3","key":"6426_CR16","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.arth.2017.09.062","volume":"33","author":"Z-Y Luo","year":"2018","unstructured":"Luo Z-Y, Wang H-Y, Wang D, Zhou K, Pei F-X, Zhou Z-K (2018) Oral vs intravenous vs topical tranexamic acid in primary hip arthroplasty: a prospective, randomized, double-blind, controlled study. J Arthroplasty 33(3):786\u2013793. https:\/\/doi.org\/10.1016\/j.arth.2017.09.062","journal-title":"J Arthroplasty"},{"key":"6426_CR17","doi-asserted-by":"publisher","first-page":"ojae044","DOI":"10.1093\/asjof\/ojae044","volume":"6","author":"SA Mess","year":"2024","unstructured":"Mess SA, Stephanos KN (2024) Temperance with tranexamic acid: increased risk of venous thromboembolism in abdominoplasty. Aesthetic Surg J Open Forum 6:ojae044. https:\/\/doi.org\/10.1093\/asjof\/ojae044","journal-title":"Aesthetic Surg J Open Forum"},{"issue":"1","key":"6426_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/jcm11010048","volume":"11","author":"J Pecold","year":"2021","unstructured":"Pecold J, Al-Jeabory M, Krupowies M, Manka E, Smereka A, Ladny JR et al (2021) Tranexamic acid for shoulder arthroplasty: a systematic review and meta-analysis. J Clin Med 11(1):48. https:\/\/doi.org\/10.3390\/jcm11010048","journal-title":"J Clin Med"},{"issue":"9","key":"6426_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14092910","volume":"14","author":"R Prejbeanu","year":"2025","unstructured":"Prejbeanu R, Mioc ML, Tsiridis E, Kenanidis E, Valli F, Pasquini A et al (2025) The influence of tranexamic acid (TXA) on postoperative infection rates following total hip arthroplasty (THA)\u2014a systematic review. J Clin Med 14(9):2910. https:\/\/doi.org\/10.3390\/jcm14092910","journal-title":"J Clin Med"},{"key":"6426_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s42836-020-00027-7","volume":"2","author":"Y Qi","year":"2020","unstructured":"Qi Y, Li Y, Wang C, Chen H, Rui Y (2020) Comparison of oral and intravenous tranexamic acid in total hip arthroplasty: a systematic review and meta-analysis. Arthroplasty 2:9. https:\/\/doi.org\/10.1186\/s42836-020-00027-7","journal-title":"Arthroplasty"},{"key":"6426_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.artd.2025.101868","volume":"38","author":"JP Rainey","year":"2025","unstructured":"Rainey JP, Fillingham YA, Hannon CP (2025) Tranexamic acid is safe and effective in reducing blood loss and transfusion rates in nearly all patients undergoing total hip and knee arthroplasty. Arthroplast Today 101868. https:\/\/doi.org\/10.1016\/j.artd.2025.101868","journal-title":"Arthroplast Today"},{"issue":"21","key":"6426_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010720","volume":"97","author":"N Stoicea","year":"2018","unstructured":"Stoicea N, Moran K, Mahmoud A-R, Glassman A, Ellis T, Ryan J et al (2018) Tranexamic acid use during total hip arthroplasty: a single center retrospective analysis. Medicine (Baltimore) 97(21):e10720. https:\/\/doi.org\/10.1097\/MD.0000000000010720","journal-title":"Medicine (Baltimore)"},{"issue":"44","key":"6426_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022999","volume":"99","author":"C Sun","year":"2020","unstructured":"Sun C, Zhang X, Chen L, Deng J, Ma Q, Cai X et al (2020) Comparison of oral versus intravenous tranexamic acid in total knee and hip arthroplasty: a GRADE analysis and meta-analysis. Medicine (Baltimore) 99(44):e22999. https:\/\/doi.org\/10.1097\/MD.0000000000022999","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"6426_CR24","doi-asserted-by":"publisher","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","volume":"156","author":"I Taeuber","year":"2021","unstructured":"Taeuber I, Weibel S, Herrmann E, Neef V, Schlesinger T, Kranke P et al (2021) Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression. JAMA Surg 156(6):e210884. https:\/\/doi.org\/10.1001\/jamasurg.2021.0884","journal-title":"JAMA Surg"},{"issue":"17","key":"6426_CR25","doi-asserted-by":"publisher","first-page":"e15279","DOI":"10.1097\/MD.0000000000015279","volume":"98","author":"N Wang","year":"2019","unstructured":"Wang N, Xiong X, Xu L, Ji M, Yang T, Tang J et al (2019) Transfusions and cost-benefit of oral versus intravenous tranexamic acid in primary total hip arthroplasty. Medicine (Baltim) 98(17):e15279. https:\/\/doi.org\/10.1097\/MD.0000000000015279","journal-title":"Medicine (Baltim)"},{"issue":"10","key":"6426_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1530\/EOR-2025-0027","volume":"10","author":"Y Wang","year":"2025","unstructured":"Wang Y, Na X, Chen T, Huang L, Chen C, Hong H (2025) Evidence on oral tranexamic acid versus intravenous tranexamic acid for perioperative blood management in total knee arthroplasty: a systematic review and meta-analysis. EFORT Open Rev 10(10):771\u2013781. https:\/\/doi.org\/10.1530\/EOR-2025-0027","journal-title":"EFORT Open Rev"},{"key":"6426_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12871-023-02261-3","volume":"23","author":"H Xiao","year":"2023","unstructured":"Xiao H, Song W, Ai H, Zhang J, Lu J, Zhang D et al (2023) Correlation between mortality and blood transfusion in patients with major surgery initially admitted to intensive care unit: a retrospective analysis. BMC Anesthesiol 23:298. https:\/\/doi.org\/10.1186\/s12871-023-02261-3","journal-title":"BMC Anesthesiol"},{"issue":"9","key":"6426_CR28","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1016\/j.arth.2017.03.059","volume":"32","author":"X Yuan","year":"2017","unstructured":"Yuan X, Li B, Wang Q, Zhang X (2017) Comparison of 3 routes of administration of tranexamic acid on primary unilateral total knee arthroplasty: a prospective, randomized, controlled study. J Arthroplasty 32(9):2738\u20132743. https:\/\/doi.org\/10.1016\/j.arth.2017.03.059","journal-title":"J Arthroplasty"}],"container-title":["Archives of Orthopaedic and Trauma Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00402-026-06426-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00402-026-06426-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T15:49:56Z","timestamp":1784476196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00402-026-06426-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6426"],"URL":"https:\/\/doi.org\/10.1007\/s00402-026-06426-w","relation":{},"ISSN":["1434-3916"],"issn-type":[{"value":"1434-3916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"263"}}